These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25594496)

  • 41. Argatroban to achieve therapeutic anticoagulation in two patients with acute thrombosis and heparin resistance.
    Mindlina I; Nelmes E; Sharp M; Butler A; Gudgin E; Thomas W
    Blood Coagul Fibrinolysis; 2019 Dec; 30(8):426-428. PubMed ID: 31567267
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
    Shapiro NL; Durr EA; Krueger CD
    Pharmacotherapy; 2006 Dec; 26(12):1806-10. PubMed ID: 17125442
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Argatroban in extracorporeal membrane oxygenation.
    Beiderlinden M; Treschan T; Görlinger K; Peters J
    Artif Organs; 2007 Jun; 31(6):461-5. PubMed ID: 17537058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alternative monitoring of argatroban using plasma-diluted thrombin time.
    Wanat MA; Hart SR; Putney D; Liebl MG; Chandler W
    Ann Pharmacother; 2013 Apr; 47(4):e18. PubMed ID: 23482736
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
    Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
    Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation.
    Thompson MH; Wilson SH; Toussaint BL; Jordan CL; Hayes GL; McKinzie BP; Wolf BJ; Field LC
    J Clin Anesth; 2016 Sep; 33():346-50. PubMed ID: 27555191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Argatroban dosing in intensive care patients with acute renal failure and liver dysfunction.
    Williamson DR; Boulanger I; Tardif M; Albert M; Grégoire G
    Pharmacotherapy; 2004 Mar; 24(3):409-14. PubMed ID: 15040656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy of aPTT monitoring in critically ill patients treated with unfractionated heparin.
    van Roessel S; Middeldorp S; Cheung YW; Zwinderman AH; de Pont AC
    Neth J Med; 2014 Jul; 72(6):305-10. PubMed ID: 25319855
    [TBL] [Abstract][Full Text] [Related]  

  • 49. An evaluation of monitoring possibilities of argatroban using rotational thromboelastometry and activated partial thromboplastin time.
    Engström M; Rundgren M; Schött U
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):86-91. PubMed ID: 19719819
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study.
    Hursting MJ; Verme-Gibboney CN
    J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Extensive prolongation of aPTT with argatroban in an elderly patient with improving renal function, normal hepatic enzymes, and metastatic lung cancer.
    Kubiak DW; Szumita PM; Fanikos JR
    Ann Pharmacother; 2005 Jun; 39(6):1119-23. PubMed ID: 15886289
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Use of argatroban as a procedural and bridging anticoagulant in a patient undergoing carotid endarterectomy with concomitant atrial fibrillation.
    Nanda MM; Kauflin MJ; Jain PG; Yannetta JC
    Ann Pharmacother; 2011 Mar; 45(3):e16. PubMed ID: 21386022
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of renal function on the pharmacodynamics of argatroban.
    Arpino PA; Hallisey RK
    Ann Pharmacother; 2004 Jan; 38(1):25-9. PubMed ID: 14742788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated partial thromboplastin time versus antifactor Xa heparin assay in monitoring unfractionated heparin by continuous intravenous infusion.
    Guervil DJ; Rosenberg AF; Winterstein AG; Harris NS; Johns TE; Zumberg MS
    Ann Pharmacother; 2011 Jul; 45(7-8):861-8. PubMed ID: 21712506
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduced argatroban doses after coronary artery bypass graft surgery.
    Hoffman WD; Czyz Y; McCollum DA; Hursting MJ
    Ann Pharmacother; 2008 Mar; 42(3):309-16. PubMed ID: 18303137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hemodialysis with a dialyzer loaded with argatroban may be performed in vivo without a systemic anticoagulant.
    Zhang Y; Ning J; Veeraragoo P; Li Y; Dai S
    Blood Purif; 2012; 33(4):300-6. PubMed ID: 22652560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.